Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza
Status:
COMPLETED
Trial end date:
2025-04-15
Target enrollment:
Participant gender:
Summary
Currently, there is only one treatment which only need one single oral dose for influenza in children five years above (Baloxavir marboxil) in China. This study will test a medicine for influenza in children younger than 5 year of age to see if it is safe and effective.
This is a multicenter, randomized, double-blind, controlled Phase III clinical study.
The study evaluates the pharmacokinetics, safety and efficacy of ADC189 tablets/granules following a single oral dose in children aged 2 to 11 years with influenza.